What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.12%
Annual Rate
CNY 0.05Paid annual
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jul 13, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.92BCNY
888.18M · vs all stocks (USD)
Updated Oct 23, 2026
Trailing P/E
81.63x
vs Engineering & Construction peers
Updated Oct 23, 2026
Revenue (TTM)
3.54BCNY
530.93M · vs all stocks (USD)
Updated Oct 23, 2026
Profit Margin
1.89%
vs Engineering & Construction peers
Updated Oct 23, 2026
Beta
1.50x
vs all stocks
Updated Oct 23, 2026
52-Week Change
41.99%
vs all stocks
Updated Oct 23, 2026
Market Capitalization
5.92BCNY
888.18M · vs all stocks (USD)
Updated Oct 23, 2026
Enterprise Value
7.06BCNY
1.06B · vs all stocks (USD)
Updated Oct 23, 2026
Trailing P/E
81.63x
vs Engineering & Construction peers
Updated Oct 23, 2026
Forward P/E
78.72x
vs Engineering & Construction peers
Updated Oct 23, 2026
Price to Sales (TTM)
1.65x
vs Engineering & Construction peers
Updated Oct 23, 2026
Price to Book (MRQ)
3.61x
vs Engineering & Construction peers
Updated Oct 23, 2026
Enterprise to Revenue
1.99x
vs Engineering & Construction peers
Updated Oct 23, 2026
Enterprise to EBITDA
29.33x
vs Engineering & Construction peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 17.9×.Updated Oct 23, 2026
Gross Margin
11.71%
vs Engineering & Construction peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 16.43%.Updated Oct 23, 2026
Profit Margin
1.89%
vs Engineering & Construction peers
Updated Oct 23, 2026
Operating Margin
4.08%
vs Engineering & Construction peers
Updated Oct 23, 2026
Return on Assets (TTM)
1.13%
vs Engineering & Construction peers
Updated Oct 23, 2026
Return on Equity (TTM)
4.08%
vs Engineering & Construction peers
Updated Oct 23, 2026
Revenue (TTM)
3.54BCNY
530.93M · vs all stocks (USD)
Updated Oct 23, 2026
Revenue per Share (TTM)
26.66CNYUpdated Oct 23, 2026
Quarterly Revenue Growth
18.60%
vs Engineering & Construction peers
Updated Oct 23, 2026
Gross Profit (TTM)
581.74MCNY
87.25M · vs all stocks (USD)
Updated Oct 23, 2026
EBITDA (TTM)
394.31MCNY
59.14M · vs all stocks (USD)
Updated Oct 23, 2026
Net Income (TTM)
67.06MCNY
10.06M · vs all stocks (USD)
Updated Oct 23, 2026
Quarterly Earnings Growth (YoY)
215.00%
vs Engineering & Construction peers
Updated Oct 23, 2026
Operating Cash Flow (TTM)
107.28MCNY
16.09M · vs all stocks (USD)
Updated Oct 23, 2026
Levered Free Cash Flow (TTM)
17.55MCNY
2.63M · vs all stocks (USD)
Updated Oct 23, 2026
Trailing Annual Dividend Rate
0.0510CNYUpdated Oct 23, 2026
Trailing Annual Dividend Yield
0.12%
vs all stocks
Updated Oct 23, 2026
Payout Ratio
0.00%
vs Engineering & Construction peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 10%.Updated Oct 23, 2026
Minority Interest (Equity)
120.70MCNYFY2025 · Dec 31, 2025
Revenue
3.51BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.93BCNYFY2025 · Dec 31, 2025
Gross Profit
576.27MCNYFY2025 · Dec 31, 2025
Operating Income
329.47MCNY
49.41M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
90.50MCNYFY2025 · Dec 31, 2025
Income Tax Expense
18.25MCNYFY2025 · Dec 31, 2025
Net Income
72.25MCNYFY2025 · Dec 31, 2025
EBIT
190.70MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
394.31MCNYFY2025 · Dec 31, 2025
Research & Development
66.00MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
62.32MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
17.99MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
12.77MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
100.21MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.5200CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.5200CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
134.51MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
134.51MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
72.25MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-2.30MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
323.43MCNYFY2025 · Dec 31, 2025
Free Cash Flow
319.88MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
923.57MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
72.25MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
73.88MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-57.47MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
234.77MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-3.55MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-60.10MCNYFY2025 · Dec 31, 2025
Sale of Investments
2.41MCNYFY2025 · Dec 31, 2025
Other Investing Activity
34.76MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-26.47MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
2.99BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-3.12BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-75.64MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-159.92MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-364.06MCNYFY2025 · Dec 31, 2025
Shares Outstanding
140.00MSharesUpdated Oct 23, 2026
Float Shares
74.02MSharesUpdated Oct 23, 2026
% Held by Insiders
48.45%
vs all stocks
Updated Oct 23, 2026
% Held by Institutions
7.77%
vs all stocks
Updated Oct 23, 2026
Total Cash (MRQ)
1.53BCNY
229.00M · vs all stocks (USD)
Updated Oct 23, 2026
Total Cash per Share (MRQ)
11.06CNYUpdated Oct 23, 2026
Total Debt (MRQ)
2.77BCNY
416.13M · vs all stocks (USD)
Updated Oct 23, 2026
Total Debt to Equity (MRQ)
1.68x
vs Engineering & Construction peers
Updated Oct 23, 2026
Current Ratio (MRQ)
1.06x
vs Engineering & Construction peers
Updated Oct 23, 2026
Book Value per Share (MRQ)
11.53CNYUpdated Oct 23, 2026
Total Assets
10.94BCNY
1.64B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
8.94BCNYFY2025 · Dec 31, 2025
Total Liabilities
9.27BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.00BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
527.08MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
8.74BCNYFY2025 · Dec 31, 2025
Cash
923.57MCNYFY2025 · Dec 31, 2025
Cash Equivalents
897.69MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.82BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
2.00MCNYFY2025 · Dec 31, 2025
Accounts Receivable
4.10BCNYFY2025 · Dec 31, 2025
Inventory
94.92MCNYFY2025 · Dec 31, 2025
Accounts Payable
4.70BCNYFY2025 · Dec 31, 2025
Short-term Debt
2.43BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
497.02MCNYFY2025 · Dec 31, 2025
Long-term Debt
519.24MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
140.00MCNYFY2025 · Dec 31, 2025
Retained Earnings
561.26MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.67BCNY
250.56M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
95.52MCNYFY2025 · Dec 31, 2025
52-Week Low
24.24CNYUpdated Oct 23, 2026
52-Week High
67.94CNYUpdated Oct 23, 2026
52-Week Change
41.99%
vs all stocks
Updated Oct 23, 2026
Beta
1.50x
vs all stocks
Updated Oct 23, 2026
50-Day MA
38.78CNYUpdated Oct 23, 2026
200-Day MA
43.67CNYUpdated Oct 23, 2026
Avg 10-Day Volume
15.85MSharesUpdated Oct 23, 2026
Avg 30-Day Volume
7.49MSharesUpdated Oct 23, 2026
Diluted EPS (TTM)
0.5100CNYUpdated Oct 23, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Significant cash reserves alongside high leverageNotable
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And DrawdownWithin or Near the Altman Distress Zone
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And DrawdownWithin or Near the Altman Distress Zone
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDecline With Range Expansion And DrawdownWithin or Near the Altman Distress Zone